Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia

Blood

Volumn 98, Issue 4, 2001, Pages 1160-1165

  Ohno, Nobuhito ^a,b,c   Tani, Ayako ^a,b,c   Uozumi, Kimiharu ^a,b,c   Hanada, Shuichi ^a,b,c   Furukawa, Tatsuhiko ^a,b,c   Akiba, Suminori ^a,b,c   Sumizawa, Tomoyuki ^a,b,c   Utsunomiya, Atae ^a,b,c   Arima, Terukatsu ^a,b,c   Akiyama, Shin Ichi ^a,b,c  

^a Institute for Cancer Research   (Japan)

^b First Department of Internal Medicine   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LUNG RESISTANCE PROTEIN; MESSENGER RNA; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SLOT BLOT HYBRIDIZATION; SURVIVAL; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 0035883049     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.4.1160     Document Type: Article

References (24)

1. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemialymphoma: A report from the Lymphoma Study Group. Br J Haematol. 1991;79:428-437.
2. Hanada S, Utsunomiya A, Suzuki S, Uozumi K, Makino T, Arima T. Treatment of adult T-cell leukemia. Cancer Chemother Pharmacol. 1997;40(suppl):S47-S50.
3. Kuwazuru Y, Hanada S, Furukawa T, et al. Expression of P-glycoprotein in adult T-cell leukemia cells. Blood. 1990;76:2065-2071.
4. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 2000;92:1295-1302.
5. Dietel M, Arps H, Lage H, Niedorf A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res. 1990;50:6100-6106.
6. Shuurhuis GJ, Broxterman HJ, de Lange JH, et al. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer. 1991;64:857-861.
7. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a Mr 110 000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 1993;53:1475-1479.
8. Scheffer GL, Wijngaard PLJ, Flens MJ, et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1995;1:578-582.
9. Kickhoefer VA, Siva AC, Kedersha NL, et al. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol. 1999;146:917-928.
10. Kickhoefer VA, Stephen AG, Harrington L, Robinson MO, Rome LH. Vaults and telomerase share a common subunit, TEP1. J Biol Chem. 1999;274:32712-32717.
11. Kerdersha N, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol. 1986;103:699-709.
12. Chugani DC, Rome LH, Kedersha N. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Sci. 1993;106:23-29.
13. Kitazono M, Sumizawa T, Takebayashi Y, et al. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst. 1999;91:1647-1653.
14. Akiyama S, Fojo AT, Hanover JA, Pastan I, Gottesman MM. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet. 1985;11:117-126.
15. Hanada S, Tsubai F, Namba Y. The characteristics of T-cell lines derived from peripheral blood of patients with adult T-cell leukemia-lymphoma. Recent Adv RES Res. 1985;25:124-133.
16. Newmyer DD, Wilson KL. Egg extracts for nuclear import and nuclear assembly reactions. Methods Cell Biol. 1991;36:607-634.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
18. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987). Leuk Res. 1991;15:81-91.
19. Filipits M, Pohl G, Stranzl T, et al. Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia. Blood. 1998:91:1508-1513.
20. List AF, Spier CS, Grogan TM, et al. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood. 1996;87:2464-2469.
21. Filipits M, Drach J, Pohl G, et al. Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma. Clin Cancer Res. 1999;5:2426-2430.
22. Raaijmakers HGP, Izquierdo MAI, Lokhorst HM, et al. Lung-resistance-related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma. Blood. 1998;91:1029-1036.
23. Sumizawa T, Chen Z-S, Chuman Y, et al. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P. Mol Pharmacol. 1997;51:399-405.
24. Kitazono M, Okumura H, Ikeda R, et al. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells. Int J Cancer. 2001;91:126-131.